Nuzenio

Onclive Dr Hurvitz

Onclive Dr Hurvitz entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 6 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Fri, 31 Jul 2026 22:53:16 GMTSecondary End Point ADC Data Add Context to HER2+ and Triple-Negative Breast Cancer Care - OncLive

Fri, 31 Jul 2026 19:49:53 GMTDr Hurvitz on Evorpacept Plus Zanidatamab in Pretreated HER2+ Metastatic Breast Cancer - OncLive

Thu, 30 Jul 2026 15:06:05 GMTDr Tolaney on Questions Regarding Treatment Duration in HER2+ Metastatic Breast Cancer - OncLive

Wed, 29 Jul 2026 03:57:54 GMTDr Hurvitz on Updated PFS Data From the SERENA-6 Trial in Breast Cancer - OncLive

Wed, 29 Jul 2026 02:23:08 GMTDr Tarantino on Updated Safety Data From DESTINY-Breast05 in HER2+ Breast Cancer - OncLive

Tue, 28 Jul 2026 22:25:57 GMTDr Tarantino on the Evolution of TROP2-Directed ADCs in First-Line TNBC - OncLive

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Onclive Dr Hurvitz.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

1 distinct publisher/source names are currently connected to this entity page.